abstract |
The present invention provides a heterocyclic compound having a structure represented by formula (I): by selecting a specific modifying group, the experimental results show that the heterocyclic compound provided by the present invention has good performance as a thyroid hormone beta receptor agonist. Active, can be used to treat and/prevent diseases caused by thyroid hormone regulation. |